Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

979 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Activity of MK-0991 (L-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp.
Marco F, Pfaller MA, Messer SA, Jones RN. Marco F, et al. Diagn Microbiol Infect Dis. 1998 Sep;32(1):33-7. doi: 10.1016/s0732-8893(98)00050-9. Diagn Microbiol Infect Dis. 1998. PMID: 9791755
Antimicrobial activity of FK-037, a new broad-spectrum cephalosporin. International in vitro comparison with cefepime and ceftazidime.
Frei R, Jones RN, Pignatari AC, Yamane N, Marco F, Hoban DJ. Frei R, et al. Diagn Microbiol Infect Dis. 1994 Mar;18(3):167-73. doi: 10.1016/0732-8893(94)90087-6. Diagn Microbiol Infect Dis. 1994. PMID: 7924209 Clinical Trial.
Trends in frequency and in vitro susceptibilities to antifungal agents, including voriconazole and anidulafungin, of Candida bloodstream isolates. Results from a six-year study (1996-2001).
Marco F, Danés C, Almela M, Jurado A, Mensa J, de la Bellacasa JP, Espasa M, Martínez JA, Jiménez de Anta MT. Marco F, et al. Diagn Microbiol Infect Dis. 2003 Aug;46(4):259-64. doi: 10.1016/s0732-8893(03)00086-5. Diagn Microbiol Infect Dis. 2003. PMID: 12944017
Elucidating the origins of nosocomial infections with Candida albicans by DNA fingerprinting with the complex probe Ca3.
Marco F, Lockhart SR, Pfaller MA, Pujol C, Rangel-Frausto MS, Wiblin T, Blumberg HM, Edwards JE, Jarvis W, Saiman L, Patterson JE, Rinaldi MG, Wenzel RP, Soll DR. Marco F, et al. J Clin Microbiol. 1999 Sep;37(9):2817-28. doi: 10.1128/JCM.37.9.2817-2828.1999. J Clin Microbiol. 1999. PMID: 10449459 Free PMC article.
In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi.
Pfaller MA, Marco F, Messer SA, Jones RN. Pfaller MA, et al. Diagn Microbiol Infect Dis. 1998 Apr;30(4):251-5. doi: 10.1016/s0732-8893(97)00246-0. Diagn Microbiol Infect Dis. 1998. PMID: 9582584
In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp.
Marco F, Pfaller MA, Messer S, Jones RN. Marco F, et al. Antimicrob Agents Chemother. 1998 Jan;42(1):161-3. doi: 10.1128/AAC.42.1.161. Antimicrob Agents Chemother. 1998. PMID: 9449278 Free PMC article.
979 results
Jump to page
Feedback